Clinical significance of serum fibroblast growth factor 23 as a surrogate marker of the cardiorenal hemodynamic state in patients with heart failure

被引：0
作者：
Imazu, M. [1 ]
Takahama, H. [1 ]
Asanuma, H. [2 ]
Funada, A. [1 ]
Ohara, T. [1 ]
Hasegawa, T. [1 ]
Asakura, M. [1 ]
Kanzaki, H. [1 ]
Anzai, T. [1 ]
Kitakaze, M. [1 ]
机构：
[1] Natl Cerebral & Cardiovasc Ctr Hosp, Dept Cardiovasc Med, Suita, Osaka, Japan
[2] Kyoto Prefectural Univ Med, Kyoto, Japan
来源：
EUROPEAN HEART JOURNAL | 2013年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：781 / 782
页数：2
相关论文
共 50 条
[41]   Fibroblast growth factor 23 and the quest for the Holy Grail in heart failure: will the Crusaders be forced to surrender? [J].
De Buyzere, Marc L. ;
Delanghe, Joris R. .
EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 (04) :710-712
[42]   FIBROBLAST GROWTH FACTOR-23 IS ASOCIATED WITH DISEASE SEVERITY AND PROGNOSIS IN CHRONIC HEART FAILURE [J].
Poelzl, Gerhard ;
Trenkler, Christian ;
Kliebhan, Johannes ;
Wuertinger, Philipp ;
Seger, Christoph ;
Kaser, Susanne ;
Mayer, Gert ;
Pirklbauer, Markus ;
Ulmer, Hanno ;
Griesmacher, Andrea .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) :A777-A777
[43]   Bone Marrow Plasma Fibroblast Growth Factor 23 Levels Are a Strong Predictor of Death in Patients With Chronic Heart Failure [J].
von Jeinsen, Beatrice ;
Sopova, Kateryna ;
Palapies, Lars ;
Fichtlscherer, Stephan ;
Seeger, Florian ;
Dimmeler, Stefanie ;
Assmus, Birgit ;
Zeiher, Andreas M. ;
Keller, Till .
CIRCULATION, 2016, 134
[44]   Bone Marrow Plasma Fibroblast Growth Factor 23 Levels Are a Strong Predictor of Death in Patients With Chronic Heart Failure [J].
Von Jeinsen, Beatrice ;
Sopova, Kateryna ;
Palapies, Lars ;
Fichtlscherer, Stephan ;
Seeger, Florian ;
Dimmeler, Stefanie ;
Assmus, Birgit ;
Zeiher, Andreas M. ;
Keller, Till .
CIRCULATION, 2016, 134
[45]   Diagnostic accuracy of fibroblast growth factor 23 for predicting acute kidney injury in patients with acute decompensated heart failure [J].
Pramong, Nattha ;
Gojaseni, Pongsathorn ;
Suttipongkeat, Sarunyoo ;
Kiattisunthorn, Kraiwiporn ;
Chittinandana, Anutra .
NEPHROLOGY, 2021, 26 (02) :126-133
[46]   Clinical usefulness of the determination of fibroblast growth factor 23 in the evaluation of patients with osteomalacia [J].
Gifre, Laia ;
Martinez de Osaba, Maria Jesus ;
Monegal, Ana ;
Guanabens, Nuria ;
Peris, Pilar .
MEDICINA CLINICA, 2014, 142 (10) :447-450
[47]   Serum troponin-I as a marker of fibroblast growth factor-23 (FGF-23) cardiotoxic effect, in patients with chronic kidney disease [J].
Taranova, M. V. ;
Milovanova, L. Yu. ;
Kozlovskaya , L. V. ;
Milovanova, S. Yu. ;
Androsova, T. V. ;
Zubacheva, D. O. ;
Lebedeva, M. V. ;
Dobrosmyslov, I. A. ;
Kozlov, V. V. ;
Kuchieva, A. M. ;
Li, O. A. ;
Reshetnikov, V. A. .
TERAPEVTICHESKII ARKHIV, 2019, 91 (06) :85-92
[48]   The effects of tenapanor on serum fibroblast growth factor 23 in patients receiving hemodialysis with hyperphosphatemia [J].
Block, Geoffrey A. ;
Rosenbaum, David P. ;
Yan, Andrew ;
Greasley, Peter J. ;
Chertow, Glenn M. ;
Wolf, Myles .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 (02) :339-346
[49]   Bone mass does not correlate with the serum fibroblast growth factor 23 in hemodialysis patients [J].
Torres, P. Urena ;
Friedlander, G. ;
de Vernejoul, M. C. ;
Silve, C. ;
Prie, D. .
KIDNEY INTERNATIONAL, 2008, 73 (01) :102-107
[50]   SERUM FIBROBLAST GROWTH FACTOR 23 LEVELS IN PATIENTS WITH HYPOPHOSPHATEMIA DUE TO FANCONI SYNDROME [J].
Goto, Shunsuke ;
Fujii, Hideki ;
Kono, Keiji ;
Nakai, Kentaro ;
Nishi, Shinichi .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 :1466-1466
12345